 | • レポートコード：MRC2102QY13420 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の低分子がん治療薬市場について種類別（サイトカイン、ヒト化モノクローナル抗体、その他）、用途別（リンパ腫、骨髄腫、前立腺がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・低分子がん治療薬市場の概要 ・世界の主要地域別低分子がん治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の低分子がん治療薬市場規模2015-2026：種類別（サイトカイン、ヒト化モノクローナル抗体、その他） ・世界の低分子がん治療薬市場規模2015-2026：用途別（リンパ腫、骨髄腫、前立腺がん、その他） ・低分子がん治療薬の米国市場規模2015-2020 ・低分子がん治療薬のヨーロッパ市場規模2015-2020 ・低分子がん治療薬の中国市場規模2015-2020 ・低分子がん治療薬の日本市場規模2015-2020 ・低分子がん治療薬の東南アジア市場規模2015-2020 ・低分子がん治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・低分子がん治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・低分子がん治療薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Small Molecule Cancer Drug Market
The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Small Molecule Cancer Drug Scope and Market Size
The global Small Molecule Cancer Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Small Molecule Cancer Drug market is segmented into
Cytokine
Humanized Monoclonal Antiboby
Others
Segment by Application, the Small Molecule Cancer Drug market is segmented into
Lymphoma
Myeloma
Prostate Cancer
Others
The Small Molecule Cancer Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Small Molecule Cancer Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Small Molecule Cancer Drug Market Share Analysis
Small Molecule Cancer Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Molecule Cancer Drug business, the date to enter into the Small Molecule Cancer Drug market, Small Molecule Cancer Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer
Cadila Pharmaceutical
Astrazeneca
Johnson & Johnson
Eli Lily
Boehringer
Roche
Merck
Novartis
1 Small Molecule Cancer Drug Market Overview
1.1 Small Molecule Cancer Drug Product Scope
1.2 Small Molecule Cancer Drug Segment by Type
1.2.1 Global Small Molecule Cancer Drug Sales by Type (2020-2026)
1.2.2 Cytokine
1.2.3 Humanized Monoclonal Antiboby
1.2.4 Others
1.3 Small Molecule Cancer Drug Segment by Application
1.3.1 Global Small Molecule Cancer Drug Sales Comparison by Application (2020-2026)
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Others
1.4 Small Molecule Cancer Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Small Molecule Cancer Drug Sales Growth Rate (2015-2026)
1.4.2 Global Small Molecule Cancer Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Small Molecule Cancer Drug Price Trends (2015-2026)
2 Small Molecule Cancer Drug Estimate and Forecast by Region
2.1 Global Small Molecule Cancer Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Small Molecule Cancer Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Small Molecule Cancer Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Small Molecule Cancer Drug Revenue Market Share by Region (2015-2020)
2.3 Global Small Molecule Cancer Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Small Molecule Cancer Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Small Molecule Cancer Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Small Molecule Cancer Drug Estimates and Projections (2015-2026)
2.4.2 Europe Small Molecule Cancer Drug Estimates and Projections (2015-2026)
2.4.3 China Small Molecule Cancer Drug Estimates and Projections (2015-2026)
2.4.4 Japan Small Molecule Cancer Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Small Molecule Cancer Drug Estimates and Projections (2015-2026)
2.4.6 India Small Molecule Cancer Drug Estimates and Projections (2015-2026)
3 Global Small Molecule Cancer Drug Competition Landscape by Players
3.1 Global Top Small Molecule Cancer Drug Players by Sales (2015-2020)
3.2 Global Top Small Molecule Cancer Drug Players by Revenue (2015-2020)
3.3 Global Small Molecule Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Cancer Drug as of 2019)
3.4 Global Small Molecule Cancer Drug Average Price by Company (2015-2020)
3.5 Manufacturers Small Molecule Cancer Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Small Molecule Cancer Drug Players (Opinion Leaders)
4 Global Small Molecule Cancer Drug Market Size by Type
4.1 Global Small Molecule Cancer Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Small Molecule Cancer Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Small Molecule Cancer Drug Price by Type (2015-2020)
4.2 Global Small Molecule Cancer Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Small Molecule Cancer Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Cancer Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Small Molecule Cancer Drug Price Forecast by Type (2021-2026)
5 Global Small Molecule Cancer Drug Market Size by Application
5.1 Global Small Molecule Cancer Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Small Molecule Cancer Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Small Molecule Cancer Drug Price by Application (2015-2020)
5.2 Global Small Molecule Cancer Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Small Molecule Cancer Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Cancer Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Cancer Drug Price Forecast by Application (2021-2026)
6 United States Small Molecule Cancer Drug Market Facts & Figures
6.1 United States Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
6.2 United States Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
6.3 United States Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
7 Europe Small Molecule Cancer Drug Market Facts & Figures
7.1 Europe Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
7.2 Europe Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
7.3 Europe Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
8 China Small Molecule Cancer Drug Market Facts & Figures
8.1 China Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
8.2 China Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
8.3 China Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
9 Japan Small Molecule Cancer Drug Market Facts & Figures
9.1 Japan Small Molecule Cancer Drug Sales Market Share by Company (3015-3030)
9.2 Japan Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
9.3 Japan Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Small Molecule Cancer Drug Market Facts & Figures
10.1 Southeast Asia Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
11 India Small Molecule Cancer Drug Market Facts & Figures
11.1 India Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
11.2 India Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
11.3 India Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Small Molecule Cancer Drug Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Small Molecule Cancer Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Cadila Pharmaceutical
12.2.1 Cadila Pharmaceutical Corporation Information
12.2.2 Cadila Pharmaceutical Business Overview
12.2.3 Cadila Pharmaceutical Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cadila Pharmaceutical Small Molecule Cancer Drug Products Offered
12.2.5 Cadila Pharmaceutical Recent Development
12.3 Astrazeneca
12.3.1 Astrazeneca Corporation Information
12.3.2 Astrazeneca Business Overview
12.3.3 Astrazeneca Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Astrazeneca Small Molecule Cancer Drug Products Offered
12.3.5 Astrazeneca Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Small Molecule Cancer Drug Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Eli Lily
12.5.1 Eli Lily Corporation Information
12.5.2 Eli Lily Business Overview
12.5.3 Eli Lily Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lily Small Molecule Cancer Drug Products Offered
12.5.5 Eli Lily Recent Development
12.6 Boehringer
12.6.1 Boehringer Corporation Information
12.6.2 Boehringer Business Overview
12.6.3 Boehringer Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Small Molecule Cancer Drug Products Offered
12.6.5 Boehringer Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Business Overview
12.7.3 Roche Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Small Molecule Cancer Drug Products Offered
12.7.5 Roche Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Small Molecule Cancer Drug Products Offered
12.8.5 Merck Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Business Overview
12.9.3 Novartis Small Molecule Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis Small Molecule Cancer Drug Products Offered
12.9.5 Novartis Recent Development
13 Small Molecule Cancer Drug Manufacturing Cost Analysis
13.1 Small Molecule Cancer Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Small Molecule Cancer Drug
13.4 Small Molecule Cancer Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Small Molecule Cancer Drug Distributors List
14.3 Small Molecule Cancer Drug Customers
15 Market Dynamics
15.1 Small Molecule Cancer Drug Market Trends
15.2 Small Molecule Cancer Drug Opportunities and Drivers
15.3 Small Molecule Cancer Drug Market Challenges
15.4 Small Molecule Cancer Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Small Molecule Cancer Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Small Molecule Cancer Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Small Molecule Cancer Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Small Molecule Cancer Drug Sales (MT) by Region (2015-2020)
Table 5. Global Small Molecule Cancer Drug Sales Market Share by Region (2015-2020)
Table 6. Global Small Molecule Cancer Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Small Molecule Cancer Drug Revenue Share by Region (2015-2020)
Table 8. Global Small Molecule Cancer Drug Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Small Molecule Cancer Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Small Molecule Cancer Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Small Molecule Cancer Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Small Molecule Cancer Drug (MT) of Key Companies (2015-2020)
Table 13. Global Small Molecule Cancer Drug Sales Share by Company (2015-2020)
Table 14. Global Small Molecule Cancer Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Small Molecule Cancer Drug Revenue Share by Company (2015-2020)
Table 16. Global Small Molecule Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Cancer Drug as of 2019)
Table 17. Global Small Molecule Cancer Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Small Molecule Cancer Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Small Molecule Cancer Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Small Molecule Cancer Drug Players
Table 22. Global Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 23. Global Small Molecule Cancer Drug Sales Share by Type (2015-2020)
Table 24. Global Small Molecule Cancer Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Small Molecule Cancer Drug Price (MT) by Type (2015-2020)
Table 26. Global Small Molecule Cancer Drug Sales Share by Type (2021-2026)
Table 27. Global Small Molecule Cancer Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Small Molecule Cancer Drug Revenue Share by Type (2021-2026)
Table 29. Global Small Molecule Cancer Drug Price (MT) by Type (2021-2026)
Table 30. Global Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 31. Global Small Molecule Cancer Drug Sales Share by Application (2015-2020)
Table 32. Global Small Molecule Cancer Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Small Molecule Cancer Drug Price (MT) by Application (2015-2020)
Table 34. Global Small Molecule Cancer Drug Sales (MT) by Application (2021-2026)
Table 35. Global Small Molecule Cancer Drug Sales Share by Application (2021-2026)
Table 36. Global Small Molecule Cancer Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Small Molecule Cancer Drug Revenue Share by Application (2021-2026)
Table 38. Global Small Molecule Cancer Drug Price (MT) by Application (2021-2026)
Table 39. United States Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 40. United States Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 41. United States Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 42. United States Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 43. United States Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 44. United States Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 46. Europe Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 48. Europe Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 50. Europe Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 51. China Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 52. China Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 53. China Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 54. China Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 55. China Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 56. China Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 58. Japan Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 60. Japan Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 62. Japan Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
Table 69. India Small Molecule Cancer Drug Sales (MT) by Company (2015-2020)
Table 70. India Small Molecule Cancer Drug Sales Market Share by Company (2015-2020)
Table 71. India Small Molecule Cancer Drug Sales (MT) by Type (2015-2020)
Table 72. India Small Molecule Cancer Drug Sales Market Share by Type (2015-2020)
Table 73. India Small Molecule Cancer Drug Sales (MT) by Application (2015-2020)
Table 74. India Small Molecule Cancer Drug Sales Market Share by Application (2015-2020)
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer Small Molecule Cancer Drug Product
Table 79. Bayer Recent Development
Table 80. Cadila Pharmaceutical Corporation Information
Table 81. Cadila Pharmaceutical Description and Business Overview
Table 82. Cadila Pharmaceutical Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cadila Pharmaceutical Small Molecule Cancer Drug Product
Table 84. Cadila Pharmaceutical Recent Development
Table 85. Astrazeneca Corporation Information
Table 86. Astrazeneca Description and Business Overview
Table 87. Astrazeneca Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Astrazeneca Small Molecule Cancer Drug Product
Table 89. Astrazeneca Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Small Molecule Cancer Drug Product
Table 94. Johnson & Johnson Recent Development
Table 95. Eli Lily Corporation Information
Table 96. Eli Lily Description and Business Overview
Table 97. Eli Lily Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eli Lily Small Molecule Cancer Drug Product
Table 99. Eli Lily Recent Development
Table 100. Boehringer Corporation Information
Table 101. Boehringer Description and Business Overview
Table 102. Boehringer Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Boehringer Small Molecule Cancer Drug Product
Table 104. Boehringer Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Small Molecule Cancer Drug Product
Table 109. Roche Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Merck Description and Business Overview
Table 113. Merck Small Molecule Cancer Drug Product
Table 114. Merck Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Small Molecule Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Small Molecule Cancer Drug Product
Table 119. Novartis Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Small Molecule Cancer Drug Distributors List
Table 123. Small Molecule Cancer Drug Customers List
Table 124. Small Molecule Cancer Drug Market Key Trends
Table 125. Small Molecule Cancer Drug Key Opportunities and Drivers
Table 126. Small Molecule Cancer Drug Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Small Molecule Cancer Drug Product Picture
Figure 2. Global Small Molecule Cancer Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Small Molecule Cancer Drug Market Share by Application in 2020 & 2026
Figure 6. Lymphoma Examples
Figure 7. Myeloma Examples
Figure 8. Prostate Cancer Examples
Figure 9. Others Examples
Figure 10. Global Small Molecule Cancer Drug Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Small Molecule Cancer Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Small Molecule Cancer Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Small Molecule Cancer Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Small Molecule Cancer Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Small Molecule Cancer Drug Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Small Molecule Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Small Molecule Cancer Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Small Molecule Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Small Molecule Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Small Molecule Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Small Molecule Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Small Molecule Cancer Drug Players Market Share by Revenue in Small Molecule Cancer Drug 2015 & 2019
Figure 28. Small Molecule Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Small Molecule Cancer Drug Revenue Share by Type (2015-2020)
Figure 30. Global Small Molecule Cancer Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Small Molecule Cancer Drug Revenue Share by Application (2015-2020)
Figure 32. Global Small Molecule Cancer Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 34. United States Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 35. Europe Small Molecule Cancer Drug Sales Market Share by Company in 2019
Figure 36. Europe Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 37. Europe Small Molecule Cancer Drug Sales Market Share by Application in 2019
Figure 38. China Small Molecule Cancer Drug Sales Market Share by Company in 2019
Figure 39. China Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 40. China Small Molecule Cancer Drug Sales Market Share by Application in 2019
Figure 41. Japan Small Molecule Cancer Drug Sales Market Share by Company in 2019
Figure 42. Japan Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 43. Japan Small Molecule Cancer Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Small Molecule Cancer Drug Sales Market Share by Application in 2019
Figure 47. India Small Molecule Cancer Drug Sales Market Share by Company in 2019
Figure 48. India Small Molecule Cancer Drug Sales Market Share by Type in 2019
Figure 49. India Small Molecule Cancer Drug Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Small Molecule Cancer Drug
Figure 52. Manufacturing Process Analysis of Small Molecule Cancer Drug
Figure 53. Small Molecule Cancer Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
プレフィルドシリンジ小分子の世界市場レポート2020 Market Analysis and Insights: Global Prefilled Syringe Small Molecule Market The global Prefilled Syringe Small Molecule market size is projected to reach US$ 13420 million by 2026, from US$ 10350 million in 2020, at a CAGR of 4.4% during 2021-2026. Global Prefilled Syringe Small Molecule Scope and …- 低分子医薬品有効成分の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Active Pharmaceutical Ingredient Market The global Small Molecule Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Activ…
- CD抗原がん治療の世界市場レポート2020 Market Analysis and Insights: Global CD Antigen Cancer Therapy Market The global CD Antigen Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global CD Antigen Cancer Therapy Scope and Market Size The global CD An…
- がん診断装置の世界市場レポート2020 Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical compan…
- がん治療用放射性ステントの世界市場レポート2020 Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer. Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson.…